Microbiome Metabolism and Metabolites: Discovery, Mechanism, and Function

January 31–February 03, 2028 | Fairmont Monte Carlo, Monte Carlo, Monaco
Scientific Organizers: Sloan Devlin, Mohamed S Donia, and Kenya Honda

  Livestream
  In Person
  On Demand
×

-

January 31–February 03, 2028 | Fairmont Monte Carlo, Monte Carlo, Monaco

Scientific Organizers: Sloan Devlin, Mohamed S Donia, and Kenya Honda

Supported by:  
Important Deadlines
Early Registration Deadline: Deadlines not yet available for this meeting.
Scholarship Deadline: Deadlines not yet available for this meeting.
Short Talk Abstract Deadline: Deadlines not yet available for this meeting.
Poster Abstract Deadline: Deadlines not yet available for this meeting.
Meeting Summary

Microbiome metabolites, produced by de novo biosynthesis or by microbial modification of dietary, host-derived, and xenobiotic molecules, mediate fundamental interactions within microbial communities and between microbes and their hosts. These molecules shape metabolism, immunity, infection, cancer, neurobiology, and responses to diet, drugs, and environmental exposures. Yet the field is still at an early stage: most microbiome-dependent molecular features detected by untargeted metabolomics remain structurally unannotated, and fewer still can be connected to the genes, organisms, pathways, and biological activities responsible for their effects.


This Keystone Symposia conference on Microbiome Metabolism and Metabolites: Discovery, Mechanism, and Function will focus on emerging strategies that close existing gaps in the field by bringing together two complementary approaches: “function to molecule” strategies that begin with host or community phenotypes and identify causal metabolites, and “molecule to function” strategies that use metabolomics, biosynthetic gene cluster analysis, microbial genetics, biochemical mechanism, and heterologous expression to discover metabolites and define their functions. Sessions will highlight advances in analytical chemistry, microbial genetics, computational prioritization, functional screening, in vivo models, and community-based approaches that reveal how microbiome-derived metabolites are generated and how they affect bacterial physiology, microbial communities, and host biology.


By bringing together analytical, organic, and biological chemists with microbiologists, immunologists, cancer biologists, metabolism researchers, computational biologists, and clinician-scientists, the conference will catalyze interdisciplinary discoveries that no single field can achieve alone. Held in conjunction with the Keystone Symposia conference on Human Microbiome: From Computation to Functions, Predictions, and Mechanisms, the conferences share a joint session that will explore how microbiome-scale datasets can be integrated with mechanistic studies of microbial products and their biological functions, giving attendees access to complementary expertise spanning population-scale discovery through causal mechanism.


Unlike broader meetings organized around community profiling, therapeutics, specific diseases, or individual technologies, this conference is centered on the mechanistic path from microbial molecules to genes, pathways, and biological function. As increasingly powerful metabolomic, genetic, and computational approaches generate candidate microbial molecules, the critical challenge is now to move from association and annotation to causal molecular mechanism.


Unique Career Development Opportunities

This meeting will feature a Career Roundtable where trainees and early-career investigators will have the opportunity to interact with field leaders from across academic and industry sectors for essential career development advice and networking opportunities. Find out more about Career Roundtables here: https://www.keystonesymposia.org/diversity/career-development-initiatives

KEYSTONE SYMPOSIA THANKS OUR GIFT-IN-KIND MEDIA SPONSORS

Subscribe for Updates